Division of Neuro-Oncology, Department of Neurology and Center of Integrated Oncology, University Hospital Bonn, Bonn, Germany
Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany
Interdisciplinary Division of Neuro-Oncology, Departments of Neurology and Neurosurgery, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany
Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart; Eberhard Karls University Tübingen, Tübingen, Germany
Department of Neuroradiology, University Hospital of Tübingen, Eberhard Karls University of Tübingen, Tübingen, Germany
Department of Radiation Oncology, University Hospital of Tübingen, Eberhard Karls University of Tübingen, Tübingen, Germany
German Consortium for Translational Oncology, German Cancer Research Center partner site Tübingen
Shared first authors
shared senior authors.
Corresponding Authors: Ghazaleh Tabatabai, MD PhD, Interdisciplinary Division of Neuro-Oncology, Hertie Institute for Clinical Brain Research, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany ([email protected]); Ulrich Herrlinger, MD, Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology, University Hospital Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany ([email protected]).
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
